Filing Details

Accession Number:
0001033905-20-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-04-16 11:26:03
Reporting Period:
2020-04-14
Accepted Time:
2020-04-16 11:26:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1033905 Luminex Corp LMNX Surgical & Medical Instruments & Apparatus (3841) 742747608
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622164 Nachum Shamir 12212 Technology Blvd
Austin TX 78727
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-04-14 45,908 $21.10 234,932 No 4 M Direct
Common Stock Disposition 2020-04-14 45,908 $30.00 189,024 No 4 S Direct
Common Stock Acquisiton 2020-04-15 79,092 $21.10 268,116 No 4 M Direct
Common Stock Disposition 2020-04-15 79,092 $30.00 189,024 No 4 S Direct
Common Stock Acquisiton 2020-04-16 125,000 $21.10 314,024 No 4 M Direct
Common Stock Disposition 2020-04-16 125,000 $31.00 189,024 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right To Buy) Acquisiton 2020-04-14 45,908 $0.00 45,908 $21.10
Common Stock Stock Option (Right To Buy) Acquisiton 2020-04-15 79,092 $0.00 79,092 $21.10
Common Stock Stock Option (Right To Buy) Acquisiton 2020-04-16 125,000 $0.00 125,000 $21.10
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
204,092 2015-10-14 2021-10-14 No 4 M Direct
125,000 2015-10-14 2021-10-14 No 4 M Direct
0 2015-10-14 2021-10-14 No 4 M Direct
Footnotes
  1. This sale is being made pursuant to a trading plan intended to comply with Rule 10b5-1 adopted by the seller on February 28, 2020 (the "Trading Plan"). The Trading Plan covered options that were otherwise set to expire in 2021. The representation regarding the seller's knowledge of material adverse non-public information speaks as of the date that the Trading Plan was adopted.